The nature of cannabis industry has changed a lot in a short period of time and this leaves a lot of questions for investors. Earlier this month, Tilray made headlines after the Canadian cannabis producer surged higher and traded as high as $300, writes Michael Berger.

Cannabis stock expert Michael Berger, president of Technical420.com, highlights one of the highest-quality licensed medical cannabis producers in Canada that is raising capital before its 2017 planned initial public offering.

For investors looking for a growth stock that is disrupting a multi-billion-dollar market, market expert Michael Berger — President of Technical420 — highlights a Canadian-based development-stage healthcare technology company that is very undervalued and has remarkable growth potential.

For investors looking for a high-growth stock operating in the fastest growing industry in the world, cannabis market expert Michael Berger - President of Technical420 - highlights a Canadian-based development-stage company that is very undervalued and has remarkable growth potential.

During the last few years, the landscape of the cannabis industry has changed, and the United States has become the most important market for the industry. Today, you will learn about the global cannabis opportunity and certain verticals of the US market that are flying under the radar. With a diverse panel of industry executives and experts, you will be able learn how they are positioned to capitalize on it.